Related Experiment Videos
Lessons from the Eker rat model: from cage to bedside
1Department of Surgery, University of Washington, Seattle, WA 98195, USA. ryeung@u.washington.edu
Current Molecular Medicine
|December 8, 2004
Summary
The Eker rat, an early model of autosomal dominant renal tumors, helped validate the "two-hit" hypothesis of carcinogenesis. This model is crucial for understanding Tuberous Sclerosis 2 (Tsc2) signaling in tumor biology and pre-clinical therapeutic evaluation.
Area of Science:
- Oncology
- Genetics
- Animal Models
Background:
- Rodent models are essential for translating research findings into clinical therapies.
- The Eker rat, an autosomal dominant model of renal tumors, predates modern genetic engineering.
- This rat strain was instrumental in validating Knudson's "two-hit" hypothesis of carcinogenesis.
Purpose of the Study:
- To highlight the Eker rat's contribution to understanding Tuberous Sclerosis 2 (Tsc2) signaling pathways.
- To review the Eker rat's utility in pre-clinical therapeutic evaluations for Tsc2-related disorders.
- To emphasize the role of the Eker rat in advancing tumor biology research.
Main Methods:
- Utilizing the Eker rat as a model organism for studying spontaneous tumor development.
- Investigating the Tsc2 germline mutation and its role in tumorigenesis.
- Leveraging historical data and contemporary research involving the Eker rat.
Main Results:
- The Eker rat provided early validation for the multi-step process of carcinogenesis.
- Identification of the Tsc2 germline mutation established the Eker rat as a model for tuberous sclerosis.
- The model has been extensively used to explore Tsc2 signaling and tumor development.
Conclusions:
- The Eker rat remains a valuable tool in oncology research.
- It facilitates the study of Tsc2-related signaling pathways and tumorigenesis.
- This model is critical for pre-clinical assessment of novel cancer therapeutics.